磷酸铬加超液碘化油和化疗药超选择介入治疗中晚期肝癌的临床观察(附30例报告)
肝肿瘤,肝肿瘤,肝动脉栓塞,32,P胶体治疗,1材料与方法,2结果,3讨论,参考文献
【摘要】 目的 探讨应用磷酸铬 32 CrPO 4 -超液碘化油( 32 P胶体-LUP)混悬液经肝动脉超选择栓塞介入治疗肝癌的方法和疗效。 方法 采用Slendinger方法,经股动脉超插至肿瘤供血动脉,注入 32 P胶体-LUP混悬液和化疗药介入治疗中晚期肝癌,单次剂量1:1。 结果 30例(观察组)接受 32 P胶体-LUP混悬液介入栓塞治疗,对肝功能Child B级也可采用,肝功能损害不大。Child A级者其6、12、18个月生存率为85.7%、64.1%和42.8%,较常规剂量对照组高(P=0.0059<0.01),Child B级者其6、12、18个月生存率也有提高,分别为56.2%、31.3%、6.25%。 结论 32 P胶体-LUP混悬液超选择肝动脉栓塞介入治疗肝癌,疗效优于常规剂量介入治疗。所有病人均能耐受该项治疗,无严重并发症。【关键词】 肝肿瘤 肝动脉栓塞 32 P胶体治疗
Clinical study on middle/advanced stage hepatic carcinoma treated with
superselective transarterial chemoembolization of colloid 32 CrPO 4 -a Report of30cases
Xu Xiaofeng,Ma Yubo,Wang Liangjin,et al.
Department of Oncology,Dachang Hospital,Shanghai200436.
【Abstract】 Objective To evaluate the efficacy of superselective transarterial chemoembolization(TACE)with colloid 32 CrPO 4 for the treatment of middle/advanced stage hepatic carcinoma.Methods Seldinger method was used for superselective TACE of proper hepatic artery.A mixed suspension of colloid 32CrPO4andchemotherapeutica-gentswasinjectedthroughthecatheter.Results TACE with colloid 32 CrPO 4 was well tolerated by the treated patients whose liver function was of Child B stagethefrequency of post-treatment hepatic insufficiency was not significantly different from that of patients treatment with routine dose of lipoidol.The colloid 32 CrPO 4 was embolized in30cases ......
您现在查看是摘要页,全文长 9885 字符。